Skype

Breast Cancer Rna Gene Expression Recurrence Risk Assessment Prognostic Classifier Suppliers

  1 suppliers  
Agendia Bv | Address: Kruislaan 406, Amsterdam 1098 SM, Netherlands
www.agendia.com | Phone: +31-(204)-622315
FDA Registration: 3004553686
Products: Breast Cancer Rna Gene Expression Recurrence Risk Assessment Prognostic Classifier (FDA Code: NYI), ...
Agendia Bv specializes in breast cancer diagnosis. Our mammaprint provides individualized metastasis risk assessment for breast cancer patients. Our unique 70-gene signature of mammaprint offers unpre more...
Sponsored Links 
 
  1 Breast Cancer Rna Gene Expression Recurrence Risk Assessment Prognostic Classifier suppliers  
FDA Code / Regulation: NYI / 866.6040
Class II - Devices subject to General Controls and Special Controls
 BROWSE BY CATEGORY > Immunology OR VIEW PRODUCTS UNDER Immunology
Browse Category   |   Alphabetical Products   |   ALL 25,000 Suppliers
HomeBuyAdd FREE ListingAdvertise Medical CompanyMedical Portal